Physician profile
Christopher Pappa
NPI 1689060667
$1,745.36
in general payments reported to CMS, 2019-2025
13 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $124 · 2021: $278 · 2022: $280 · 2023: $40.88 · 2024: $450 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $461.73 | 2022-2025 | Ngenuity, Clareon, Rocklatan |
| Abbvie INC. | $292.88 | 2022-2025 | |
| Glaukos Corporation | $219.44 | 2025 | Idosetr |
| Allergan, INC. | $152.75 | 2021-2022 | |
| Sight Sciences, INC. | $141.99 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Aerie Pharmaceuticals, INC. | $123.74 | 2020 | |
| Novartis Pharmaceuticals Corporation | $119.44 | 2021 | |
| Thea Pharma INC. | $63.23 | 2024-2025 | Iyuzeh |
| Bausch & Lomb Americas INC. | $44.16 | 2023-2024 | Vyzulta, Miebo |
| Tarsus Pharmaceuticals, INC. | $37.68 | 2024 | Xdemvy |
| Omeros Corporation | $35.19 | 2021 | |
| New World Medical,INC. | $32.61 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Beaver-Visitec International, INC. | $20.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Pappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.